How can we help you?
See what we're contributing at 2021 ICPE All Access and who'll be there virtually to catch up with!
We've grown from 26 employees at RTP in 2000 to over 350 worldwide in 2020.
We'll help you navigate and understand the emerging ISPOR/ISPE Real World Evidence guidelines.
The paradigm of regenerative medicine development is changing. Our experienced team can help you stay on track.
Learn how a Market Access Evidence Roadmap can help you identify areas of evidence generation required to support reimbursement and increase access to your product.
The consortium working on EMA-funded MINERVA Project to aid RWD use, is being led by RTI-HS